Recently, mutations in the polycomb repressive complex (PRC) pathway were discovered in the BC genome, with PRC2 directing DNA hypermethylation and silencing genes involved in myeloid differentiation and with tumor suppressor function and PRC1 repressing similar and novel tumor suppressors [78]. The gene discussed is PRC1; the disease is neoplasm.